Alignment Healthcare (NASDAQ:ALHC) EVP Sells $575,000.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) EVP Joseph Konowiecki sold 25,000 shares of the business’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $23.00, for a total value of $575,000.00. Following the transaction, the executive vice president directly owned 1,128,816 shares in the company, valued at approximately $25,962,768. This trade represents a 2.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Stock Performance

Shares of ALHC traded up $0.50 during mid-day trading on Friday, reaching $23.21. The company’s stock had a trading volume of 6,548,273 shares, compared to its average volume of 4,330,164. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The business has a 50-day simple moving average of $18.72 and a two-hundred day simple moving average of $19.55. The stock has a market cap of $4.80 billion, a P/E ratio of 257.84, a PEG ratio of 2.93 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter in the prior year, the business earned ($0.05) EPS. The firm’s revenue for the quarter was up 33.3% on a year-over-year basis. As a group, equities research analysts anticipate that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on ALHC. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. UBS Group boosted their target price on shares of Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Weiss Ratings upgraded shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Wolfe Research assumed coverage on shares of Alignment Healthcare in a research note on Friday, April 17th. They issued an “outperform” rating and a $24.00 price objective for the company. Finally, Raymond James Financial set a $22.00 target price on shares of Alignment Healthcare in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $24.30.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ALHC. Allworth Financial LP increased its stake in shares of Alignment Healthcare by 8.9% in the fourth quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock valued at $137,000 after buying an additional 566 shares during the period. State of Alaska Department of Revenue boosted its position in Alignment Healthcare by 6.0% during the 4th quarter. State of Alaska Department of Revenue now owns 11,296 shares of the company’s stock worth $223,000 after buying an additional 636 shares during the period. Integrated Wealth Concepts LLC grew its holdings in Alignment Healthcare by 6.3% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock worth $196,000 after acquiring an additional 665 shares during the last quarter. Parallel Advisors LLC increased its position in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the period. Finally, Tidal Investments LLC increased its position in Alignment Healthcare by 4.9% in the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company’s stock valued at $253,000 after acquiring an additional 852 shares during the period. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.